Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where HSDT advanced for three days, in 169 of 202 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Aroon Indicator entered an Uptrend today. In 60 of 81 cases where HSDT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.
The 10-day RSI Indicator for HSDT moved out of overbought territory on September 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 10 similar instances where the indicator moved out of overbought territory. In 9 of the 10 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Momentum Indicator moved below the 0 level on October 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HSDT as a result. In 76 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for HSDT turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 34 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 87%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSDT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
HSDT broke above its upper Bollinger Band on September 18, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. HSDT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.012) is normal, around the industry mean (3.263). P/E Ratio (0.014) is within average values for comparable stocks, (27.022). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.319). HSDT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.081). P/S Ratio (11.574) is also within normal values, averaging (15.860).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HSDT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where MLCI declined for three days, in 63 of 76 cases, the price declined further within the following month. The odds of a continued downward trend are 83%.
The 10-day RSI Indicator for MLCI moved out of overbought territory on September 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 7 similar instances where the indicator moved out of overbought territory. In 2 of the 7 cases, the stock moved lower in the following days. This puts the odds of a move lower at 29%.
The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MLCI as a result. In 17 of 28 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.
The Moving Average Convergence Divergence Histogram (MACD) for MLCI turned negative on October 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 16 similar instances when the indicator turned negative. In 8 of the 16 cases the stock turned lower in the days that followed. This puts the odds of success at 50%.
MLCI moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.
MLCI broke above its upper Bollinger Band on September 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +6.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where MLCI advanced for three days, in 24 of 39 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
The Aroon Indicator entered an Uptrend today. In 20 of 41 cases where MLCI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 49%.
The Tickeron Valuation Rating of 10 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.656) is normal, around the industry mean (3.263). P/E Ratio (1.137) is within average values for comparable stocks, (27.022). Projected Growth (PEG Ratio) (0.350) is also within normal values, averaging (1.319). Dividend Yield (0.034) settles around the average of (0.081) among similar stocks. P/S Ratio (0.367) is also within normal values, averaging (15.860).
The Tickeron PE Growth Rating for this company is 63 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 78 (best 1 - 100 worst), indicating slightly worse than average price growth. MLCI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 97 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MLCI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
HSDT | MLCI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 40 | 78 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 92 Overvalued | 10 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 97 | |
SMR RATING 1..100 | 99 | 99 | |
PRICE GROWTH RATING 1..100 | 44 | 78 | |
P/E GROWTH RATING 1..100 | 6 | 63 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MLCI's Valuation (10) in the null industry is significantly better than the same rating for HSDT (92) in the Medical Specialties industry. This means that MLCI’s stock grew significantly faster than HSDT’s over the last 12 months.
MLCI's Profit vs Risk Rating (97) in the null industry is in the same range as HSDT (100) in the Medical Specialties industry. This means that MLCI’s stock grew similarly to HSDT’s over the last 12 months.
MLCI's SMR Rating (99) in the null industry is in the same range as HSDT (99) in the Medical Specialties industry. This means that MLCI’s stock grew similarly to HSDT’s over the last 12 months.
HSDT's Price Growth Rating (44) in the Medical Specialties industry is somewhat better than the same rating for MLCI (78) in the null industry. This means that HSDT’s stock grew somewhat faster than MLCI’s over the last 12 months.
HSDT's P/E Growth Rating (6) in the Medical Specialties industry is somewhat better than the same rating for MLCI (63) in the null industry. This means that HSDT’s stock grew somewhat faster than MLCI’s over the last 12 months.
| HSDT | MLCI | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 29% |
| Stochastic ODDS (%) | 1 day ago 81% | 1 day ago 50% |
| Momentum ODDS (%) | 1 day ago 90% | 1 day ago 61% |
| MACD ODDS (%) | 1 day ago 87% | 1 day ago 50% |
| TrendWeek ODDS (%) | 1 day ago 90% | 1 day ago 63% |
| TrendMonth ODDS (%) | 1 day ago 83% | 1 day ago 43% |
| Advances ODDS (%) | 9 days ago 84% | 17 days ago 62% |
| Declines ODDS (%) | 7 days ago 90% | 7 days ago 83% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 73% |
| Aroon ODDS (%) | 1 day ago 74% | 1 day ago 49% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HSDT’s FA Score shows that 1 FA rating(s) are green while MLCI’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HSDT’s TA Score shows that 3 TA indicator(s) are bullish while MLCI’s TA Score has 3 bullish TA indicator(s).
HSDT (@Investment Managers) experienced а -11.65% price change this week, while MLCI (@Investment Managers) price change was -3.14% for the same time period.
The average weekly price growth across all stocks in the @Investment Managers industry was -3.42%. For the same industry, the average monthly price growth was -2.82%, and the average quarterly price growth was -3.87%.
HSDT is expected to report earnings on Nov 05, 2026.
MLCI is expected to report earnings on Nov 06, 2026.
Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FLCB | 20.46 | 0.04 | +0.20% |
| Franklin U.S Core Bond ETF (FLCB) | |||
| CBOO | 24.30 | 0.01 | +0.04% |
| Calamos Bitcoin Structured Alt Protection ETF - October (CBOO) | |||
| TCPB | 48.54 | 0.01 | +0.03% |
| Thrivent Core Plus Bond ETF | |||
| JANZ | 42.20 | N/A | -0.01% |
| TrueShares Structured Outcome (January) ETF (JANZ) | |||
| SIHY | 44.10 | -0.11 | -0.25% |
| Harbor Ares Systematic High Yield ETF (SIHY) | |||
A.I.dvisor indicates that over the last year, HSDT has been loosely correlated with MLCI. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if HSDT jumps, then MLCI could also see price increases.
| Ticker / NAME | Correlation To HSDT | 1D Price Change % | ||
|---|---|---|---|---|
| HSDT | 100% | -1.67% | ||
| MLCI - HSDT | 60% Loosely correlated | +1.65% | ||
| DFDV - HSDT | 56% Loosely correlated | -1.85% | ||
| ASST - HSDT | 45% Loosely correlated | -0.43% | ||
| AMBR - HSDT | 33% Poorly correlated | +6.52% | ||
| HSCS - HSDT | 32% Poorly correlated | -6.36% | ||
More | ||||
A.I.dvisor indicates that over the last year, MLCI has been loosely correlated with HSDT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if MLCI jumps, then HSDT could also see price increases.
| Ticker / NAME | Correlation To MLCI | 1D Price Change % | ||
|---|---|---|---|---|
| MLCI | 100% | +1.65% | ||
| HSDT - MLCI | 60% Loosely correlated | -1.67% | ||
| GCMG - MLCI | 29% Poorly correlated | -1.83% | ||
| HLNE - MLCI | 27% Poorly correlated | -4.59% | ||
| TPG - MLCI | 26% Poorly correlated | -4.94% | ||
| CRBG - MLCI | 25% Poorly correlated | -0.52% | ||
More | ||||